Page last updated: 2024-12-11

beta-apo-10'-carotenal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-apo-10'-carotenal: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

10'-apo-beta-carotenal : An apo carotenoid compound arising from oxidative degradation of the beta,beta-carotene skeleton at the 10'-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6450190
CHEBI ID53153
SCHEMBL ID2831303
MeSH IDM0389781

Synonyms (19)

Synonym
beta-apo-10'-carotenal
10'-apo-beta-carotenal, all-trans-
640-49-3
10'-apo-beta-caroten-10'-al
10'-apo-beta,psi-carotenal
10'-apo-beta-carotenal
all-trans-10'-apo-beta-carotenal
CHEBI:53153
(2e,4e,6e,8e,10e,12e,14e)-4,9,13-trimethyl-15-(2,6,6-trimethylcyclohexen-1-yl)pentadeca-2,4,6,8,10,12,14-heptaenal
C20695
SCHEMBL2831303
Q27123983
DTXSID701315499
apo-beta,psi-carotenal, 10'-
2,4,6,8,10,12,14-pentadecaheptaenal, 4,9,13-trimethyl-
(2e,4e,6e,8e,10e,12e,14e)-4,9,13-trimethyl-15-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8,10,12,14-pentadecaheptaenal
2,4,6,8,10,12,14-pentadecaheptaenal, 4,9,13-trimethyl-15-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-e)-
2,4,6,8,10,12,14-pentadecaheptaenal, 4,9,13-trimethyl-15-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2e,4e,6e,8e,10e,12e,14e)-
D8AT287SHE
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
enalAn alpha,beta-unsaturated aldehyde of general formula R(1)R(2)C=CR(3)-CH=O in which the aldehydic C=O function is conjugated to a C=C double bond at the alpha,beta position.
apo carotenoidA compound arising from loss of part of the carotene skeleton (excluding retinoids)
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (7)

PathwayProteinsCompounds
Metabolism14961108
Metabolism of vitamins and cofactors146155
Metabolism of fat-soluble vitamins2623
Retinoid metabolism and transport2217
Visual phototransduction6241
carotenoid cleavage620
Sensory Perception21568
carotenoid cleavage422

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's9 (75.00)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]